175 related articles for article (PubMed ID: 29703160)
1. SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.
Chen J; Cao Z; Guan J
BMC Cardiovasc Disord; 2018 Apr; 18(1):72. PubMed ID: 29703160
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
[TBL] [Abstract][Full Text] [Related]
3. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
[TBL] [Abstract][Full Text] [Related]
4. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability.
Xiong Y; Yu Y; Montani JP; Yang Z; Ming XF
J Am Heart Assoc; 2013 Jul; 2(4):e000096. PubMed ID: 23832324
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR
Thompson D; Morrice N; Grant L; Le Sommer S; Lees EK; Mody N; Wilson HM; Delibegovic M
Clin Sci (Lond); 2017 Oct; 131(20):2489-2501. PubMed ID: 28899902
[TBL] [Abstract][Full Text] [Related]
6. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques.
Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH
Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862
[TBL] [Abstract][Full Text] [Related]
7. PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions.
He L; Zhou Q; Huang Z; Xu J; Zhou H; Lv D; Lu L; Huang S; Tang M; Zhong J; Chen JX; Luo X; Li L; Chen L
J Cell Physiol; 2019 Jun; 234(6):8668-8682. PubMed ID: 30456860
[TBL] [Abstract][Full Text] [Related]
8. Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.
Barnes RH; Akama T; Öhman MK; Woo MS; Bahr J; Weiss SJ; Eitzman DT; Chun TH
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735290
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Vascular Calcification.
Liu L; Zeng P; Yang X; Duan Y; Zhang W; Ma C; Zhang X; Yang S; Li X; Yang J; Liang Y; Han H; Zhu Y; Han J; Chen Y
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2382-2395. PubMed ID: 30354214
[TBL] [Abstract][Full Text] [Related]
10. Artesunate inhibits atherosclerosis by upregulating vascular smooth muscle cells-derived LPL expression via the KLF2/NRF2/TCF7L2 pathway.
He LH; Gao JH; Yu XH; Wen FJ; Luo JJ; Qin YS; Chen MX; Zhang DW; Wang ZB; Tang CK
Eur J Pharmacol; 2020 Oct; 884():173408. PubMed ID: 32739175
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
12. The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
Zhuang J; Luan P; Li H; Wang K; Zhang P; Xu Y; Peng W
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):84-97. PubMed ID: 27879253
[TBL] [Abstract][Full Text] [Related]
13. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
14. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
15. P2Y
Niu X; Pi SL; Baral S; Xia YP; He QW; Li YN; Jin HJ; Li M; Wang MD; Mao L; Hu B
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):515-524. PubMed ID: 28062501
[TBL] [Abstract][Full Text] [Related]
16. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
17. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis.
Kim J; Jang SW; Park E; Oh M; Park S; Ko J
J Mol Cell Cardiol; 2014 Jul; 72():157-67. PubMed ID: 24650873
[TBL] [Abstract][Full Text] [Related]
18. Oxidized Low-Density Lipoprotein-Induced Cyclophilin A Secretion Requires ROCK-Dependent Diphosphorylation of Myosin Light Chain.
Su Z; Lin R; Chen Y; Shu X; Zhang H; Liang S; Nie R; Wang J; Xie S
J Vasc Res; 2016; 53(3-4):206-215. PubMed ID: 27825172
[TBL] [Abstract][Full Text] [Related]
19. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
